We think it is important to think ahead and to consider what issues the medical industry will be facing in the future. As we near 2015 we’ve decided to use this as a half-way point. In this infographic we’ve reflected on significant global changes over the last 15 years and looked at the forecasts for the next 15. The result is a glimpse of what challenges healthcare will face in 2030. Can we do anything today to change the future? Or if we accept this vision of the future what do we need to do now to best prepare?

1. Healthcare
in
Po pulation Less developed r egions
M ore developed regions
The middle class “The middle class is an ambiguous social classification, broadly reflecting the ability t o lead a comfortable life. The middle class usually enjoy stable housing, healthcare a nd educational opportunities (including college) for their children, reasonable retirement and job security, and discretionary income that c an be spent on vacation and l eisure pursuits.” D r Homi Kharas in a research paper for the OECD, 2011
The burden of poor hea lth in 2030 will present some tough choices for a ll involved. The constant and necessary push to reduce costs will see patients become central to their own healthcare, with many expected to treat and monitor themselves in the hom e. It will also place a considerable burd en on healthcare professionals who’ll n eed to treat and care for people efficiently and effectively.
Leading causes of death in 2030
The top 10 causes of death (2000 v 2030)
The estimated global direct and indirect costs of illness in 2030
Number of middle class people
Ageing N umber of people over 65 2000 420m 2030 973m
Obesity
2000 2030
2000 2005 2010 2015 2020 2025 2030
4.88 bn
2030
1.3bn
2000
Geographic spread of the global middle class
2009 2020 2030
North
America
Europe Central &
South America
Asia
Pacific
Sub-Saharan
Africa
Middle East
& North Africa
0 – 4
5 – 14
15 – 29
30 – 49
50 – 69
70 +
All
0% 10%
Communicable,
maternal, perinatal &
nutritional conditions
Noncommunicable
diseases
Injuries (accidental
& intentional)
20% 30% 40% 50% 60% 70% 80% 90% 100%
Age range
Ischaemic Heart Disease
COPD
Hypertensive Heart Disease
Stroke
Lower Respiratory Infections
Cirrhosis of the liver
2000
5,974,000
people
11.3%
of all deaths
2000
3,059,000
people
5.8%
of all deaths
2000
849,000
people
1.6%
of all deaths
2000
5,662,000
people
10.7%
of all deaths
2000
3,491,000
people
6.6%
of all deaths
2000
892,000
people
1.7%
of all deaths
2030
9,245,000
people
13.2%
of all deaths
2030
4,568,000
people
6.5%
of all deaths
2030
1,457,000
people
2.1%
of all deaths
2030
8,578,000
people
12.2%
of all deaths
HIV/AIDS Diarrhoeal Diseases
2000
1,678,000
people
3.2%
of all deaths
2000
2,171,000
people
4.1%
of all deaths
2030
1,793,000
people
2.6%
of all deaths
2030
1,617,000
people
2.3%
of all deaths
2030
3,535,000
people
5%
of all deaths
2030
1,201,000
people
1.7%
of all deaths
Diabetes Mellitus Trachea, Bronchus, Lung Cancers
2000
1,046,000
people
2%
of all deaths
2000
1,164,000
people
2.2%
of all deaths
2030
2,464,000
people
3.5%
of all deaths
2030
2,413,000
people
3.4%
of all deaths
2.16bn
Overweight
1.12bn
Obese
750 m
Overweight
300m
Obese
COPD Cardiovascular
disease
Diabetes Cancer
2030 $4,800bn $1,040bn $741bn $458bn
2010
$ 2,100bn $863bn $472bn $290bn
Population data United Nations (http://te-am.co/pop2030)
Age data Centers for Disease Control and Prevention (http://te-am.co/age2030)
Obesity data International Journal of Obesity (http://te-am.co/obesity2030)
Middle class data OECD (http://te-am.co/class2030) and Brookings (http://te-am.co/midclass2030)
Causes of death data World Health Organization (http://te-am.co/death2030)
Cost of healthcare data World Economic Forum and Harvard School of Public Health (http://te-am.co/costs2030)
team-consulting.com/2030
2bn
3bn
4bn
5bn
6bn
7bn
8bn
9bn
2010 2030